RLMD
Relmada Therapeutics·NASDAQ
--
--(--)
--
--(--)
RLMD Filings
Filing Date
Form Description
Form Type
2026-03-20
Form 8-K - Current report
Key Events
2026-03-20 · Key Events
Form 8-K - Current report
2026-03-19
Relmada Therapeutics, Inc.(RLMD)-20260320-2025 Q4 Earnings call transcript
Earnings Call
2026-03-19 · Earnings Call
Relmada Therapeutics, Inc.(RLMD)-20260320-2025 Q4 Earnings call transcript
2026-03-19
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-19 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-09
Form 8-K - Current report
Key Events
2026-03-09 · Key Events
Form 8-K - Current report
2026-02-17
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-17 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-17
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-17 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-12
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-12 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-06
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-06 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-01-30
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-01-30 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-12-16
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-16 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
